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INTRODUCTION 
Diabetes mellitus (DM) is a chronic condition that can 
have a major impact on life expectancy and quality of 
life, especially if undetected or poorly controlled.
1
 The 
two major classifications of DM are type 1 (insulin 
deficient) and type 2 (combined insulin resistance and 
relative deficiency in insulin secretion). They differ in 
clinical presentation, onset, etiology, drug therapy, and 
progression of disease. Both are associated with 
microvascular and macrovascular disease complications 
that may affect the productivity and quality of life 
inevitably.
2
 
International Diabetes Federation’s (IDF) most recent 
estimates in 2013 indicate that 8.3% of adults – 
382 million people – have diabetes, and  the number of 
people with the disease is set to rise beyond 592 million 
in less than 25 years. Yet, with 175 million of cases 
currently undiagnosed, a vast amount of people with 
diabetes are progressing towards complications 
unawares. Moreover, with 80% of the total number 
affected living in low- and middle-income countries, 
where the epidemic is gathering pace at alarming rates, 
the IDF Diabetes Atlas’ latest figures provide a 
worrying indication of the future impact of diabetes as a 
major threat to global development.
3
 
The prevalence of diabetes mellitus is increasing in 
developing countries due to population growth, aging, 
unhealthy diets, obesity and sedentary lifestyles.
4
 
Diabetes reduces life expectancy by 5 to 10 years. 
Premature cardiovascular disease is the most common 
cause of mortality.
5
 Indeed, coronary heart disease is 
already the leading cause of mortality in some 
developing countries.
6
 
In sub-Saharan Africa in particular, the condition is 
even worse due to late diagnosis and poor access to 
diabetes care.
5
 Diabetes is common in Ethiopia but the 
incidence and prevalence of the disease is not well 
known in the community; diabetes has never been given 
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the attention it deserves in Ethiopia.
6,7
 The number of 
people with diabetes (20-79 years), 2013 in Ethiopia is 
estimated to be between 1 million to 10 million.
3
 
The primary goals of DM management are to reduce the 
risk for microvascular and macrovascular disease 
complications, to ameliorate symptoms, to reduce 
mortality, and to improve quality of life.
2
 Near-normal 
glycemia will reduce the risk for development of 
microvascular disease complications, but aggressive 
management of traditional cardiovascular risk factors 
(i.e., smoking cessation, treatment of dyslipidemia, 
intensive blood pressure control, and antiplatelet 
therapy) are needed to reduce the likelihood of 
development of macrovascular disease.
8
 
Appropriate care requires goal setting for glycemia, 
blood pressure, and lipid levels, regular monitoring for 
complications, dietary and exercise modifications, 
medications, appropriate self-monitored blood glucose 
(SMBG), and laboratory assessment of the for 
mentioned parameters.
9
  
The aim of this study was to assess utilization pattern of 
antidiabetic medication in patients attending Hiwot 
Fana Specialized University Hospital Diabetic Clinic, 
Harar, Ethiopia. 
METHOD AND MATERIALS 
Study area and period 
The study was conducted in Harar Hiwot Fana 
Specialized University Hospital, which is one of the 
governmental hospitals found in the Harari Regional 
State that provides service to the community and is 
under administration of Haramaya University. The 
diabetic clinic which is under the chronic disease clinic 
has a total 305 registered diabetic patients on follow-up. 
The study was carried out from April 1 to May 31, 
2014.  
Study design 
A cross-sectional study was conducted on patients 
attending Diabetic Clinic of HFSUH by using a 
structured questionnaire and data collection format. The 
data were collected by reviewing patient card and 
interviewing patients. Exclusion criteria was diabetic 
patients who were not registered but on follow-up. 
Data processing and analysis 
The data were coded, entered and analyzed with the 
help of SPSS window program version 16. Descriptive 
statistics was used for most variables and Chi-square 
test was used to test the association among variables. P-
value of < 0.05 was used as statistically significant 
value. Average blood sugar, which refers to the average 
of the last three months consecutive FBS, measures 
were used.  
Ethical consideration  
Institutional Research Ethics Review Committee of 
College of Medical and Health Sciences, Haramaya 
University approved this study. The participants 
provided a verbal informed consent because some of the 
study participants were illiterate so it was not possible 
to have a written consent from them.  Each participant 
was introduced and briefed about the purpose and 
objective of the study and unwilling individuals were 
left over. The Ethics Review Committee of the College 
also approved the consent procedure. The 
confidentiality of the patients was also secured by not 
using their names and card number in the data 
collection tools during data collection. 
RESULT  
Socio- demographic characteristics 
A total of 296 diabetic patients were involved in this 
study with response rate of 97.3%; 170 (57.4%) were 
females. Socio-demographic characteristics of the 
diabetic patients is shown in Table 1. 
 
Background information of patients 
Two hundred and twenty three (75.3%) of the 
respondents were diagnosed with type-2 diabetes. 
Family history of DM was reported by 79(26.7%) of 
patients, with the proportion being higher among type 2 
patients 68(86%). Almost all (99.3%) patients were on 
pharmacologic therapy at the time of the study (Figure 
1). 
 
Figure 1: Frequency distribution of diabetic 
management in patients attending HFSUH Diabetic 
Clinic, April 1 to May 31, 2014.
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Table 1: Socio-demographic characteristics of patients in HFSUH Diabetic Clinic, April 1 to May 31, 2014. 
 
Among those who were on pharmacological therapy, majority of them 127 (42.9%) were taking insulin alone as shown 
in Figure 2.  
 
Figure 2:  Prescribing pattern of antidiabetic medication in HFSUH Diabetic Clinic, April 1 to May 31, 2014. 
 
Patients practice towards antidiabetic drug 
utilization 
Almost all patients (98.8%) on oral medication kept 
their drugs in safe place. Majority of patients 93(65%) 
who were either on insulin therapy alone or in 
combination with OGLA used   two syringes for 
monthly consumption (Table 2). Ninety six (67.1%) and 
33(23.1%) patients used traditional places prepared and 
fridge for insulin storage, respectively.  
 
Table 2: Frequency distribution of syringe number used by patients in HFSUH Diabetic Clinic, April 1 to May 
31, 2014. 
 
 
 
 
 
No     Variables   No % 
1 Gender Male 126 42.6 
Female 170 57.4 
2 Age <14 6 2 
15-29 41 13.9 
30-44 68 23 
45-59 133 44.9 
>60 48 16.2 
3 Religion Orthodox 102 34.5 
Muslim 184 35.4 
Protestant 19 6.4 
Other 11 3.7 
4 Marital status Single 45 15.5 
Married 207 69.9 
Divorced 20 6.8 
Widowed 24 8.1 
5 Educational status Unable to write and read 174 58.8 
Grade 1-8 67 22.6 
Grade 8-12 51 17.2 
Graduated 4 1.4 
6 Residence Urban 192 64.9 
Rural 104 35.1 
Syringe number Frequency Percentage 
Valid 2 93 65.0 
 4 17 11.9 
5-10 24 16.8 
.>10 9 6.3 
Total 143 100.0 
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Fifty one (35.7%) patients used only their arm as insulin 
injection site (Table 3). One hundred and twenty five 
(87.4%) patients rotated insulin injection site and from 
those who rotated, 55(44%) used the same injection 
site. Twenty three (16%) had developed lipodystrophy 
and 9 of them injected in the lipodystrophied site.  
 
Table 3: Frequency distribution of injection site used by patients in HFSUH Diabetic Clinic, April 1 to May 31, 
2014 
 
 
 
 
 
 
 
 
Monitoring and the incidence of microvascular 
complication                                                                          
Most of the patients 277(93.6%) had blood sugar 
monitoring once per month and the remaining 10(3.4%) 
had two times and only 9(3%) had more than four times 
monitoring habit.  The average FBS of patients during 
last 3 consecutive visits was 181.3 mg/dl (Table 4).  
 
Table 4: Average FBS value of patients for the last three consecutive months in HFSUH Diabetic Clinic, April 1 
to May 31, 2014. 
 
 
 
 
 
 
 
 
Most of the patients (202) were complaining of microvascular complications. From these, 28 of them complained of 
having neuropathy, nephropathy and sight problems and 48 patients had nephropathy with sight problem (Figure 3). 
 
Figure 3: Frequency distribution of microvascular complication in patients attending HFSUH Diabetic Clinic, 
April 1 to May 31, 2014. 
 
Injection site Frequency Percentage 
Valid Abdomen 17 11.9 
 Thigh 9 6.3 
Arm 51 35.7 
Thigh and arm 44 30.8 
All but not buttock 22 15.4 
Buttock 0 0 
Total 143 100.0 
Average blood glucose level Frequency Percent 
Valid <70 6 2.0 
 70-130 118 39.9 
130-200 116 39.2 
200-250 36 12.2 
250-300 14 4.8 
300-600 6 2.0 
Total 296 100.0 
Legend: 
A-neuropathy+sight problem+nephropathy 
B- sight problem+nephropathy 
C-neuropathy 
D-sight problem 
E-nephropathy 
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The most common co-existing illness 82(49.1%) was 
found to be hypertension, followed by chronic kidney 
disease 31(18.5%), heart failure 10(16.7%), arthritis 
9(5.9%) and  asthma 5(2.9%), respectively. Ten of them 
(16.7%) had both hypertension and heart failure.  
A total of 750 drugs were prescribed during the study 
period. From those, 389 (51.86%) were antidiabetic 
medications. The average number of drugs per 
prescription were 2.5 with minimum of one drug for 
77(26%) and maximum of 7 drug for four (1.4%) 
patients per prescription. Most of the patients 186(62.8) 
had free drug access.  
From drugs which were prescribed for managing 
diabetes related complication and co-morbid illness, 
angiotensin converting enzyme inhibiters (ACEI) 
accounts for the largest portion that were prescribed for 
104(28.8%) patients (Table 5). 
 
Table 5: Frequency of mostly prescribed drugs for treating co-morbid illness and complication in HFSUH 
Diabetic Clinic, April 1 to May 31, 2014 
Drug name Frequency Percentage (%) 
ACEI 104 28.8 
Hydrochlorothiazide  68 18.8 
Aspirin 36 9.9 
NSAID 20 5.5 
Amitriptyline 30 8.3 
Acetaminophen  12 3.3 
Multivitamins 22 6.1 
Statin 16 4.4 
B-blocker 9 2.5 
CCB 6 1.6 
Antibiotics  40 11.1 
 
From the total 296 patients, 215(72.6%) and 222(%) 
had never examined their eyes and kidneys, respectively 
and 68(23%) and 69(%) had examined their eyes and 
kidneys once, respectively. Weight measurement was 
not practiced by 173(58.4%) patients while 99(33.4%) 
and 23(7.7%) patients had occasional and monthly 
weight measurement, respectively.                                                                                                                                                
Most of the patients 186(62.4%) confirmed that they did 
not use any substance (chat, cigarette, alcohol and 
shisha); whereas 85(28.6%) patients chewed chat and 
18(6%), 3(1%) and 1(0.33%) used alcohol, cigarette 
and shisha, respectively. 
DISCUSSIONS 
The study attempted to assess the utilization of 
antidiabetic medication. Among the 296 diabetic 
patients in this study, the majority 223(75.3%) were 
type II which might be consistent with other reports in 
the country but higher as compared to the western 
countries; this might be  due to diagnosis merely 
dependent on age of onset and clinical presentation 
rather than antibody test.
10
 
The study revealed that the mean FBS of patients during 
the last three consecutive month visits was found to be 
180.3 mg/dl. More than half of the patients (58.1%) had 
FBS level above 130 mg/dl and 6(2%) had lower FBS 
level from the goal of therapy, which were higher than a 
study done in Jimma, where FBS level was 171.7 ± 63.6 
mg/dl. The mean FBS levels of 73.1% of patients was 
found to be above 130 mg/dl, showing large deviation 
from the goal of therapy indicating poor blood glucose 
control despite the fact that most of them 186(62.8%) 
were taking medications provided free of charge.
6 
Even though sex, age, residence, marital status and cost 
of drug did not show significant association with the 
average FBS value, educational status showed 
significant relation (p < 0.05) which showed similar 
trend with the previous study in the area. Individuals 
with elementary educational status were four times 
more likely to perform self care than those who were 
unable to read and write.
4
 
Almost all patients were on pharmacological therapy for 
their diabetes at the time and only two patients were 
undergoing lifestyle modifications alone. From 
pharmacological agents, insulin was being used alone or 
in combination with OGLA, accounting for the largest 
proportion (48.3%). The study in Jimma showed all 
diabetic patients were on pharmacologic therapy except 
for one patient and more than half of the patients were 
taking insulin alone or in combination with OGLA.
6
 A 
small number decrement on insulin use in the study area 
might be either due to a small proportion of type 1 DM 
patients or most of type 2 DM patients were respondent 
for OGLA only. The lower number of patients on non-
pharmacological therapy might be due to lack of routine 
medical check-up and lack of knowledge of diabetic 
symptoms which resulted in patients presenting only 
when they were overtly sick.                                                                    
Whereas, a study in India showed that the most 
frequently prescribed drug for diabetic patients was 
insulin (80.5%), followed by biguanides, 
sulfonylureas.
11
 The lower utilization of biguanides in 
local studies might be due to existence of 
contraindication or low information dissemination about 
survival benefit of metforimin. 
Majority of the patients 93(65%) on insulin used two 
syringes for monthly consumption. However, 
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manufacturers recommend that syringes must be used 
only once to ensure sterility, prevent tissue damage, 
decrease injection site pain and prevent infection.
12
 The 
reasons for long term use of syringes in the study area 
might be due to inability to afford or shortage of 
supplies. Ninety six (67.1%) patients used place 
prepared for insulin storage which should be 
appreciated and encouraged but 14(9.8%) used wrong 
storage conditions which might lead to loss of 
pharmacologic activity. Most of the patients (94.4%) 
used opened vial for less than 28 days and the 
remaining used for more than 28 days, which did not 
comply with the manufacturers' instructions, i.e., 
opened insulin vial should be used for 28 days.
13
 The 
reason for their usage could be due to inability to afford 
and lack of awareness.  
Majority of the patients rotated 125(87.4%) injection 
site and 88 of patients rotated with different major site 
after each injection, which was not in consistent with 
the American association of diabetes educators 
guideline which states rotation is typically made within 
the general area rather than from major site to site and 
the panel also noted that the thigh is the preferred site 
for NPH insulin to ensure optimal absorption.
12 
This might be due to lack of awareness, and 
recklessness.  From those who developed 
lipodystrophy, nine of them injected in it and eight of 
them did not have reason to do so and only one 
preferred because there was no pain around it but 
lipohypertrophy has been linked to poorer glycemic 
control and may reduce absorption by as much as 25%; 
this might be due to not rotating site or use of syringes 
repeatedly.
13
 
As the study result revealed that 9(3%) patients 
practiced self monitored blood glucose level (SMBGL) 
which corresponds with most studies in the country
6,8
; 
this might be due to inability to afford as it is expensive. 
From these patients, 66.7% had controlled blood 
glucose level. A study done in Malaysia also showed a 
significant decrease in HbA1c level  in patients who 
practiced SMBGL.
14
 This might be because the practice 
improved medication adherence and motivated patients 
to make necessary lifestyle changes and need to be 
encouraged.  
From the total patients, 202(68.2%) had complained of 
at least one microvascular complication and 174(58.7%) 
of patients had neuropathy which is followed by 
101(50%) sight problem and 79(39.1%) nephropathy. 
Whereas, the study done in Jimma showed 160(52.5%) 
patients had one or more of the chronic complications, 
the major ones being neuropathy in 90(29.5%), 
nephropathy in 48(15.7%) and visual disturbances in 
103 (33.8%).
10
 Our study had indicated much higher 
complication rate which might be due to poor blood 
glucose control that is an average of 180.3 mg/dl as 
compared to 171 mg/dl in Jimma, as near-normal 
glycemia reduces the risk of microvascular disease 
complications.
2
 The result of the study showed poor 
control with respect to goal set by American diabetic 
association. A prospective diabetes study in U.K. 
showed that each 1% reduction in HbA1c was 
associated with a 37% decrement in risk for 
microvascular complications but measurement of 
HbA1c was not done in our setting.
14
 
Polypharmacy, which is one of the major problems in 
managing DM, was observed in our study setting due to 
high incidence of comorbid diseases and complications. 
In this study, the average number of drugs per 
prescription was 2.5 with minimum of one drug for 
77(26%) and maximum of 7 drugs for 4(1.4%) patients 
per prescription; this might not be considered to be 
polypharmacy  as it does not comply with the definition 
that states use of five or more regular medications as 
polypharmacy.
[15]
 A study in Nepal showed the average 
number of drugs per prescription was 6.51±2.3 and all 
prescriptions contained more than one drug, 17.6% of 
prescriptions contained 2 to 4 drugs, 71.13% of 
prescriptions contained 5 to 9 drugs, and 10.54 % of 
prescriptions contained 10 or more drugs.
16
   
From drugs which were prescribed for managing 
diabetes related complication and comorbid illnesses, 
ACEI accounted for the largest portion 104(28.8%) 
patients. This could be because of higher incidence of 
hypertension, CKD and heart failure, which is similar 
with different studies.
6,10,17,18
 
CONCLUSIONS  
The majority of patients were with type II diabetics and 
the most prescribed antidiabetic medication was insulin, 
followed by glibenclamide and metformin, respectively. 
Blood glucose controls were far below any 
recommended standard for most of the patients. The 
average FBS value was associated with the educational 
status of patients significantly showing as educational 
level rose there was better blood glucose level control. 
More than half of the patients used two syringes for 
monthly consumption. Most of the patients rotated 
major injection site and some of them also injected on 
lipodystrophied site. Very small number of patients 
practiced SMBGL and significant blood glucose control 
were observed. Monitoring for microvascular 
complication was poor even though the incidence of 
microvascular complications was higher with peripheral 
neuropathy being the most common.  
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